Donglu Kang Pharmaceutical Co., LTD. (referred to as Lu Kang Pharmaceutical) is a state-controlled comprehensive pharmaceutical enterprise. It was established in 1966 and listed on the main board of the Shanghai Stock Exchange in 1997 (stock code :600789).
Lu Kang Pharmaceutical has total assets of 7.3 billion yuan, over 6,000 employees, and a total of 13 wholly-owned and controlled or participating companies. The main business covers major industrial sectors such as human active pharmaceutical ingredients, human pharmaceutical preparations, animal and plant health care drugs, bio-organic fertilizers and environmental protection technology. With over 200 product registration numbers and more than 500 varieties and specifications, 67 specifications rank among the top ten in the country, and 18 specifications rank first in the country. The company has passed the national GMP certification, ISO9000 series, ISO14001, and occupational health and safety management system certification. It has also obtained international high-end certifications such as the US FDA and the European CEP. Its products are exported to over 40 countries and regions.
